Global framework on essential health R&D
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Only 10 of 1556 new drugs produced between 1975 and 2004 were targeting diseases specifically prevalent in poor and low-income countries.
“Another study also found that only 10 of 1556 new drugs produced between 1975 and 2004 were targeting diseases specifically prevalent in poor and low-income countries [20].”
From Barriers for conducting clinical trials in developing countries—A systematic review (2018) · cites this paper as [20]
Cites
Drug development for neglected diseases: a deficient market and a public-health policy failure
Trouiller, P., Olliaro, P., Torreele, E., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09096-7 · Cited by 900 · see citing works
Self-citationAccess to Essential Drugs in Poor Countries
Pécoul, B., Chirac, P., Trouiller, P., & Pinel, J. (1999) · JAMA · doi:10.1001/jama.281.4.361 · Cited by 396 · see citing works
Self-citationDrug development output from 1975 to 1996: What proportion for tropical diseases?
Trouiller, P., & Olliaro, P. (1999) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(99)90010-3 · Cited by 88 · see citing works
Drug development for neglected diseases
de Francisco, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11170-6 · Cited by 22 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Barriers for conducting clinical trials in developing countries—A systematic review
Alemayehu, C., Mitchell, G., & Nikles, J. (2018) · International Journal for Equity in Health · doi:10.1186/s12939-018-0748-6 · Cited by 406 · see citing works
“Another study also found that only 10 of 1556 new drugs produced between 1975 and 2004 were targeting diseases specifically prevalent in poor and low-income countries [20].”
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Hoen, E. '., Berger, J., Calmy, A., & Moon, S. (2011) · Journal of the International AIDS Society · doi:10.1186/1758-2652-14-15 · Cited by 334 · see citing works
“Manifesto” for Advancing the Control and Elimination of Neglected Tropical Diseases
Hotez, P. J., & Pecoul, B. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000718 · Cited by 138 · see citing works
- Authors
- Chirac, P., & Torreele, E.
- Affiliations
- Médecins Sans Frontières (FR)
- Drugs for Neglected Diseases Initiative (CH)
- Corresponding author
- Chirac, Pierre
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 367
- Issue
- 9522
- Pages
- 1560-1561
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2141149556
- Cited by
- 165
- References
- 4
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 7 · 2018: 6 · 2017: 1 · 2016: 5 · 2015: 10 · 2014: 5 · 2013: 16 · 2012: 14
- FWCI
- 31.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Medecins Sans Frontieres Field Research (Medecins Sans Frontieres) (submittedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Biotechnology and Related Fields
- Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
- Keywords
- neglected diseases, pharmaceutical industry, drug development, tropical diseases, developing countries, World Health Assembly resolution
- MeSH terms
- Developing Countries, Humans, Orphan Drug Production, Research, Tropical Medicine, Global Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
